Variant position: 410 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 616 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MLAKAVAAESNATFFNISAA SLTSKYVGEGEKLVRALFAVA
Mouse MLAKAVAAESNATFFNISAA SLTSKYVGEGEKLVRALFAVA
Rat MLAKAVAAESNATFFNISAA SLTSKYVGEGEKLVRALFAVA
Pig MLAKAVAAESNATFFNISAA SLTSKYVGEGEKLVRALFAVA
Bovine MLAKAVAAESNATFFNISAA SLTSKYVGEGEKLVRALFAVA
Chicken MLAKAVAAESNATFFNISAA SLTSKYVGEGEKLVRALFAVA
Xenopus laevis MLAKAVAAESNATFFNISAA SLTSKYVGEGEKLVRALFSVA
Xenopus tropicalis MLAKAVAAESNATFFNISAA SLTSKYVGEGEKLVRALFSVA
Zebrafish MLAKAVAMESNATFFNISAA TLTSKYVGEGEKLVRALFAVA
Caenorhabditis elegans LLAKAVAGESKQMFFNISAS SLTSKWVGDSEKTIRGLFQIA
Drosophila LLARAVATECSATFLNISAA SLTSKYVGDGEKLVRALFAVA
Slime mold MIAKAVAYESKVTFFSISSS SLTSKYVGDGEKLVRALFAVA
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 616 Spastin
78 – 616 Cytoplasmic
228 – 616 Sufficient for microtubule severing
415 – 415 Y -> A. Abrogates binding to the tail of alpha-tubulin and beta-3-tubulin, impairs ATPase activity and abolishes microtubule severing.
408 – 412
Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia.
Alvarez V.; Sanchez-Ferrero E.; Beetz C.; Diaz M.; Alonso B.; Corao A.I.; Gamez J.; Esteban J.; Gonzalo J.F.; Pascual-Pascual S.I.; Lopez de Munain A.; Moris G.; Ribacoba R.; Marquez C.; Rosell J.; Marin R.; Garcia-Barcina M.J.; Del Castillo E.; Benito C.; Coto E.;
BMC Neurol. 10:89-89(2010)
Cited for: VARIANTS SPG4 THR-287 DEL; LEU-293; LEU-328; ARG-378; HIS-380; PRO-391; 393-LYS--ALA-396 DEL; THR-409; ARG-410; PRO-436; ASN-441; SER-460; ALA-463; PHE-492; GLY-498; ARG-503 INS; GLY-514 AND THR-580;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.